Sheila Fleming with Lawson Impact Award

Sheila Fleming at the 2018 Lawson Impact Awards

Sheila Fleming recognized for her support of Lawson’s entire administration team and research community

Off­site - 

Sheila Fleming, executive assistant to Dr. David Hill, scientific director of Lawson Health Research Institute, was the recipient of a Staff Award of Excellence at the 2018 Lawson Impact Awards event this past spring.

In addition to carrying out her administrative support functions for Dr. Hill – in itself a significant responsibility – Fleming goes above and beyond to provide support in a variety of ways to the entire Lawson administration team and research community.

Chris Pin

Chris Pin, PhD, lead author on the study, has found that mutation of a gene called ATRXmay lead to increased risk of developing pancreatitis and pancreatic cancer in females.

Study marks first time a sex-specific genetic risk factor for pancreatic cancer has been identified

LHSC: Victoria Hospital - 

In a new study from Lawson Health Research Institute and Western University’s Schulich School of Medicine & Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females. The study marks the first time a sex-specific genetic risk factor for pancreatic cancer has been identified.

Dr. David Hill

Dr. David Hill, scientific director at Lawson

A column by Dr. David Hill, scientific director at Lawson

The following column was provided to Hospital News by Dr. David Hill, scientific director, Lawson Health Research Institute. 

Dedicated health researchers across the country are working every day to make discoveries that improve patient outcomes and support a higher quality of life. Our research hospitals have a mandate to develop and test new treatments, technologies and procedures that address our most pressing health challenges.

Pages